- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02900391
Urgent Care for the Elderly: Impairment and Home Care Services (EPIGER)
September 8, 2016 updated by: Anne-Laure Feral-Pierssens, European Georges Pompidou Hospital
Elderly population is increasing quickly and their need for health care ressources through emergency care is also growing. While these patients are ageing physical impairment often happens along the way. Apart from senior homes, different types and levels of home care services have been developped in order to overcome or to adapt to these situations.
Our goals are:
- to assess mortality rate depending on home care services level for the elderly population consulting in the ED or being taken in charge by the Emergency Medical System in France.
- to describe this population in terms of autonomy, impairment and home care services
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
3200
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
80 years and older (Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
All patients aged 80 and over visiting the ED, taking in charge by SMUR (medical EMS) or calling SAMU (medical call center) during 24 hours
Description
Inclusion Criteria:
- patients aged 80 and over
Exclusion Criteria:
- aged<80 years old
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mortality rate at hospital discharge
Time Frame: At hospital discharge or 30 days at most
|
Mortality rate at hospital discharge
|
At hospital discharge or 30 days at most
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Admission rate
Time Frame: Admission is decided on the first 24 hours after EMS or ED care, the day of the inclusion
|
Admission in a medical, surgical or psychiatric unit are considered
|
Admission is decided on the first 24 hours after EMS or ED care, the day of the inclusion
|
Level of home care services
Time Frame: Questionnaires given the day of the inclusion
|
Different items in a questionnaire are asked to the patient or family concerning weekly home care services use for patient usually (which type and how often)
|
Questionnaires given the day of the inclusion
|
Level of health care ressources
Time Frame: During the ED visit (less than 24 hours), the day of the inclusion
|
Lab investigations, radiology, surgery, treatment administered
|
During the ED visit (less than 24 hours), the day of the inclusion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2016
Primary Completion (Actual)
March 1, 2016
Study Completion (Actual)
March 1, 2016
Study Registration Dates
First Submitted
September 1, 2016
First Submitted That Met QC Criteria
September 8, 2016
First Posted (Estimate)
September 14, 2016
Study Record Updates
Last Update Posted (Estimate)
September 14, 2016
Last Update Submitted That Met QC Criteria
September 8, 2016
Last Verified
September 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- EPIGER
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Impaired
-
University of LiegeCompleted
-
Jacobs University Bremen gGmbHLiveonline CoachingCompletedMotivation | Impaired HealthGermany
-
Finnish Institute for Health and WelfareEuropean Commission; Hospital District of Helsinki and UusimaaCompleted
-
Western Kentucky UniversityEnrolling by invitationDriving ImpairedUnited States
-
Rhode Island HospitalCompleted
-
Public Dental Health, VarmlandKarolinska InstitutetCompleted
-
Maimonides Medical CenterCompletedImpaired ThermoregulationUnited States
-
University of LausanneUniversity Hospital, Geneva; University of Lausanne HospitalsCompleted
-
Aalborg University HospitalCompleted
-
TCI Co., Ltd.Recruiting